2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-22
±³À°ÀÏÀÚ : 2023-04-22
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : 2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ : herz8@circulation.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ-100,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-70,000ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ-120,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-90,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-22 Convention Hall 3 09:00~09:20 How To Properly Assess for Venous Disease? ±èÇöÁø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-22 Convention Hall 3 09:20~09:40 Venous Disease Treatment: Conservative Treatments ±è´ë¿µ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 04-22 Convention Hall 3 09:40~10:00 Interventional Therapy for Acute Pulmonary Embolism Juyong Lee(University of Connecticut School of Medicine USA)
±³À°½Ã°£ 04-22 Convention Hall 3 10:00~10:20 Surgical Management of Chronic Venous Insufficiency Patrick Muck(TriHealth Heart Institute Cincinnati USA)
Åä·Ð 04-22 Convention Hall 3 10:20~10:30 Discussion ()
ÈÞ½Ä 04-22 10:30~10:40 Break ()
±³À°½Ã°£ 04-22 Convention Hall 2 10:40~11:00 Inflammatory Myocardial Disease: Overview ±èÁöÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-22 Convention Hall 2 11:00~11:20 Tissue Characterization by CMR: Can CMR Maintain the Current Position in the Future? ±è¼º¸ñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-22 Convention Hall 2 11:20~11:40 Myocardial Tissue and Metabolism Characterization by PET: PET can do What Others Cannot Á¶»ó°Ç(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-22 Convention Hall 2 11:40~12:00 Echocardiography with the Potential of Tissue Characterization: Echocardiography hasn¡¯t Given up yet Either À±¿¬ÀÌ(¼¿ïÀÇ´ë)
Åä·Ð 04-22 Convention Hall 2 12:00~12:10 Discussion ()
ÈÞ½Ä 04-22 12:10~12:15 Break ()
±³À°½Ã°£ 04-22 Rm.210 12:15~12:55 Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 04-22 12:55~13:10 Break ()
±³À°½Ã°£ 04-22 Rm.214 13:10~13:25 Normal Cardiopulmonary Response to Exercise Àº¿µ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-22 Rm.214 13:25~13:40 Exercise Stress Echocardiography ±è¼ºÇý(Â÷ÀÇ´ë)
±³À°½Ã°£ 04-22 Rm.214 13:40~13:55 How to Perfom Cardiopulmonary Exercise Testing ³ªÀçÀ±(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-22 Rm.214 13:55~14:10 Special Consideration for Children & Adults with CHD during CPET ¼Û¹Ì°æ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-22 Rm.214 14:10~14:25 Interpretation of CPET Â÷½½±â(¿ï»êÀÇ´ë)
Åä·Ð 04-22 Rm.214 14:25~14:40 Discussion ()
ÈÞ½Ä 04-22 14:40~14:50 Break ()
±³À°½Ã°£ 04-22 Rm.210 14:50~15:10 Pro: Fibrate Still Has a Role in CV Risk Reduction ±è³²ÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-22 Rm.210 15:10~15:30 Cons: Reducing TG Does Not Lower CV Risk ¿À±Ôö(°¡Å縯ÀÇ´ë)
Åä·Ð 04-22 Rm.210 15:30~16:10 Discussion ()